Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in
Home>News>This Article

Immune Cells Cluster and Communicate ‘Like Bees,’ Researcher Says

Published: Tuesday, March 19, 2013
Last Updated: Tuesday, March 19, 2013
Bookmark and Share
UCSF study on T-cell behavior sheds light on how vaccines work.

The immune system’s T cells, while coordinating responses to diseases and vaccines, act like honey bees sharing information about the best honey sources, according to a new study by scientists at UC San Francisco.

“In the morning, each bee goes looking individually for a sugar source, then comes back to the hive and does a dance in front of the other bees describing the location of what it’s found, which helps the hive decide collectively where the best source is,” said senior scientist Matthew Krummel, PhD, a UCSF professor of pathology.

They don’t bust the same moves as bees, but T cells gather together and communicate essential information to each other in a similar way, Krummel said, thereby helping to coordinate immune responses directed against invading pathogens. This discovery might lead to useful therapeutic interventions to fight disease, according to Krummel.

Results of the study were published online March 10 in Nature Immunology.

Helping the Immune System to Recognize a Pathogen

Krummel’s lab team found that after individual T cells survey lymph nodes and sample foreign matter, such as vaccines, bacteria or viruses, they come together as a group during what he and his team call the “critical differentiation period.” This occurs several hours to one day after exposure.

“They cluster together for the purpose of sharing information, transmitting what they’ve discovered about the new pathogen or vaccine, which in turn helps the immune system mount a coordinated response to the foreign matter,” Krummel said.

The discovery is important, Krummel said, because it sheds light on an aspect of medicine that has long been obscure: how vaccines work. “We know that they are effective for years after a vaccination, but we don’t know why. It seems that T-cell aggregation is a profound part of the reason.”

Krummel’s team found that the critical differentiation period is essential to the formation of what is known as a “memory pool,” the mechanism by which the immune system recognizes a pathogen to which it had been exposed months or years previously.

“Without that long-term memory, vaccines would be useless,” Krummel said. “The body wouldn’t remember that it had been exposed to a particular pathogen, such as measles or diphtheria, and would not know how to successfully fight it off.”

In experiments with a mouse model of human immune function, the scientists vaccinated mice for listeria, a common bacterium that causes food-borne illness, and then exposed the animals to the bacteria.

Mice in which the critical differentiation period was allowed to occur unimpeded remained healthy, protected from a potentially lethal infection. In mice in which T-cell differentiation was blocked, said Krummel, “it was as if the mice had never been vaccinated at all.”

Krummel said the work also opens up new paths of research in immunology, which his laboratory is currently pursuing. “Now that we know that there is a nexus at which the cells are integrating their responses, we might be able to design cells that will join that nexus in order to get the cells to do things we want them to do – push immune response in a particular direction, or enhance it overall,” he said.

Conversely, Krummel speculated that in case of autoimmune disorders, such as diabetes or lupus, “it might be possible to attenuate the immune response by blocking the formation of a memory pool.”

“You can’t eliminate insulin, which is what much of the immune response is reacting to in diabetes,” he said. “But if you can tweak the immune cells in the right way, then although each cell would be responding to insulin, they would not be reacting as a group and thus may not become effective at killing the insulin-producing cells. That would severely weaken the autoimmune effect."

Krummel cautioned that while the mouse model of human immune response is “robust and very well-grounded,” research will ultimately have to take place in humans, “which will be years away. We’ll have to see what happens.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Opening the Door to Safer, More Precise Cancer Therapies
New method regulates when, and how strongly, cancer-killing therapeutic T cells are activated.
Tuesday, September 29, 2015
Nanosponge Vaccine Fights MRSA Toxins
Nanosponges that soak up a dangerous pore-forming toxin produced by MRSA could serve as a safe and effective vaccine against this toxin.
Wednesday, December 04, 2013
Potential New Drug for Inflammatory Bowel Disease
Vedolizumab, a new intravenous antibody medication, has shown positive results for treating both Crohn's disease and ulcerative colitis.
Monday, September 02, 2013
Study Finds Potential Medical Uses for Algae
Can scientists rid malaria from the Third World by simply feeding algae genetically engineered with a vaccine?
Monday, April 22, 2013
FDA Names Breast Cancer Drug a Breakthrough Therapy
An experimental drug being investigated for the treatment of advanced breast cancer by researchers at UCLA this week received breakthrough therapy designation from the U.S. FDA.
Monday, April 15, 2013
Antimalarial Drug Launched
Twelve years after a breakthrough discovery in his UC Berkeley laboratory, professor of chemical engineering Jay Keasling is seeing his dream come true.
Friday, April 12, 2013
Engineered Small-Pox Vaccine may Kill Liver Cancer
As part of a multicenter clinical trial, researchers at University of California are evaluating Pexa-Vec (JX-594) to slow the progression of hepatocellular carcinoma (HCC) or liver cancer.
Thursday, April 11, 2013
Biologists Engineer Algae to Make Complex Anti-Cancer ‘Designer’ Drug
Biologists at UC San Diego have succeeded in genetically engineering algae to produce a complex and expensive human therapeutic drug used to treat cancer.
Thursday, December 13, 2012
Strengthening Proteins with Polymers
Researchers describe how they synthesized polymers to attach to proteins in order to stabilize them during shipping, storage and other activities.
Tuesday, May 22, 2012
Scientific News
Boosting Breast Cancer Treatment
To more efficiently treat breast cancer, scientists have been researching molecules that selectively bind to cancer cells and deliver a substance that can kill the tumor cells, for several years.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Speeding Up the Process of Making Vaccines
System uses a freeze-dry concept to develop "just-add-water" solution.
Surprising Trait Found in Anti-HIV Antibodies
Scientists at The Scripps Research Institute (TSRI) have new weapons in the fight against HIV.
New Method Identifies Up to Twice as Many Proteins and Peptides
An international team of researchers developed a method that identifies up to twice as many proteins and peptides in mass spectrometry data than conventional approaches.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Single Vaccine for Chikungunya, Related Viruses May be Possible
What if a single vaccine could protect people from infection by many different viruses? That concept is a step closer to reality.

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos